Evidence map›Paper›PMID 31570589›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

The

Dorian Marckmann, Petru-Iulian Trasnea, Johannes Schimpf, Christine Winterstein, Andreea Andrei, Stefan Schmollinger, Crysten E Blaby-Haas, Thorsten Friedrich, Fevzi Daldal, Hans-Georg Koch

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. CrpH ofFrontiers in microbiology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Copper delivery to an endospore coat protein ofFrontiers in cell and developmental biology · 2022
    Article
  11. The CopA2-Type PFrontiers in microbiology · 2021
    Article
  12. Maturation ofFrontiers in microbiology · 2021
    Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Dorian MarckmannInstitute of Biochemistry and Molecular Biology, Zentrum für Biochemie und Molekulare Zellforschung, Faculty of Medicine, Albert Ludwigs University of Freiburg, 79104 Freiburg, Germany.
Petru-Iulian TrasneaDepartment of Biology, University of Pennsylvania, Philadelphia, PA 19104.
Johannes SchimpfInstitute of Biochemistry, Faculty of Chemistry and Pharmacy, Albert Ludwigs University of Freiburg, 79104 Freiburg, Germany.
Christine WintersteinDepartment of Biology, University of Pennsylvania, Philadelphia, PA 19104.
Andreea AndreiInstitute of Biochemistry and Molecular Biology, Zentrum für Biochemie und Molekulare Zellforschung, Faculty of Medicine, Albert Ludwigs University of Freiburg, 79104 Freiburg, Germany.
Stefan SchmollingerDepartment of Plant & Microbial Biology, University of California, Berkeley, CA 94720.
Crysten E Blaby-HaasBiology Department, Brookhaven National Laboratory, Upton, NY 11973.
Thorsten FriedrichInstitute of Biochemistry, Faculty of Chemistry and Pharmacy, Albert Ludwigs University of Freiburg, 79104 Freiburg, Germany.
Fevzi DaldalDepartment of Biology, University of Pennsylvania, Philadelphia, PA 19104; fdaldal@sas.upenn.edu hans-georg.koch@biochemie.uni-freiburg.de.
Hans-Georg KochInstitute of Biochemistry and Molecular Biology, Zentrum für Biochemie und Molekulare Zellforschung, Faculty of Medicine, Albert Ludwigs University of Freiburg, 79104 Freiburg, Germany; fdaldal@sas.upenn.edu hans-georg.koch@biochemie.uni-freiburg.de.ORCID 0000-0001-5913-0334
University of Freiburg · DEUniversity of Pennsylvania · USBrookhaven National Laboratory · USUniversity of California, Berkeley · US

Funding

Respiratory Complex III: Supercomplexes and ROS, from Bacteria to HumanR01GM038237 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI DALDAL, M. FEVZI · 1987 to 2018
$5.9M
Nutritional Cu Signaling and HomeostasisR01GM042143 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SABEEHA MERCHANT · 1995 to 2026
$4.6M
Nutritional Copper Signaling and HomeostasisR37GM042143 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MERCHANT, SABEEHA · 2011 to 2020
$4.3M
NIGMS NIH HHS R01 GM038237NIGMS NIH HHS R01 GM042143NIGMS NIH HHS R37 GM042143
6 · The paper itself

Abstract

Copper (Cu)-containing proteins execute essential functions in prokaryotic and eukaryotic cells, but their biogenesis is challenged by high Cu toxicity and the preferential presence of Cu(II) under aerobic conditions, while Cu(I) is the preferred substrate for Cu chaperones and Cu-transport proteins. These proteins form a coordinated network that prevents Cu accumulation, which would lead to toxic effects such as Fenton-like reactions and mismetalation of other metalloproteins. Simultaneously, Cu-transport proteins and Cu chaperones sustain Cu(I) supply for cuproprotein biogenesis and are therefore essential for the biogenesis of Cu-containing proteins. In eukaryotes, Cu(I) is supplied for import and trafficking by cell-surface exposed metalloreductases, but specific cupric reductases have not been identified in bacteria. It was generally assumed that the reducing environment of the bacterial cytoplasm would suffice to provide sufficient Cu(I) for detoxification and cuproprotein synthesis. Here, we identify the proposed

Indexed as

Bacterial ProteinsCopperCytoplasmElectron Transport Complex IVMolecular ChaperonesOxidoreductasesRhodobacter capsulatusBacterial ProteinsCopperElectron Transport Complex IVMolecular ChaperonesOxidoreductasescoppercytochrome oxidasehomeostasismembrane protein biogenesisRhodobacter capsulatus

Identifiers

PMID31570589
PMCPMC6800367
OpenAlexW2978928781

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.